Contents
Current Drug Safety, Volume 1 - Number 3
NSAID Use and the Risk of Parkinsons Disease
, 1(3): 223 - 225Mahyar Etminan and Samy Suissa
DOI: 10.2174/157488606777934404
The Role of Atypical Antipsychotic Agents in the Treatment of Schizophrenia and Schizoaffective Disorders in the Elderly
, 1(3): 227 - 241Subramoniam Madhusoodanan, Abhishek Sinha, Martha Sajatovic, Sanjay Gupta and Ronald Brenner
DOI: 10.2174/157488606777934468
Safety Profile of Plasmid/Liposomes and Virus Vectors in Clinical Gene Therapy
, 1(3): 253 - 257Thomas Wirth, Marja Hedman, Kimmo Makinen, Hannu Manninen, Arto Immonen, Matti Vapalahti and Seppo Yla-Herttuala
DOI: 10.2174/157488606777934440
Adverse Dermatological Reactions in Rheumatoid Arthritis Patients Treated with Etanercept, an Anti-TNFα Drug
, 1(3): 259 - 264Shyra Rajakulendran and Chris Deighton
DOI: 10.2174/157488606777934495
Oral Antiplatelet Agents and Bleeding Risk in Relation to Major Cardiovascular Surgery
, 1(3): 281 - 287James McCaslin, Jonathan Smout, Patrick Kesteven and Gerard Stansby
DOI: 10.2174/157488606777934486
Antiepileptic Drug-Induced Hypersensitivity Syndrome Reactions
, 1(3): 289 - 299Norberto Krivoy, Masud Taer and Manuela G. Neuman
DOI: 10.2174/157488606777934459
Drug-Induced Hair Disorders
, 1(3): 301 - 305Bianca Maria Piraccini, Matilde Iorizzo, Giulia Rech and Antonella Tosti
DOI: 10.2174/157488606777934477
Evaluating Drug Safety in Children and Adolescents with Bipolar Disorder
, 1(3): 307 - 318Pamela C. Heaton, Colleen M. Garlick and Doan Tran
DOI: 10.2174/157488606777934396
Webmaster Contact: info@benthamscience.org